Facebook
Twitter
Telegram
Report an ErrorOvid Therapeutics Financial Statements 2011-2024 | OVID
Annual Financial Statements Ovid Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
221 M | 142 M | 186 M | 167 M | 135 M | 78.6 M | 161 M | - | - | - | - | - | - |
Shares |
70.6 M | 70.4 M | 67.5 M | 59.4 M | 39.2 M | 24.6 M | 19.3 M | - | - | - | - | - | - |
Historical Prices |
3.13 | 2.01 | 2.76 | 2.81 | 3.6 | 2.83 | 8.5 | - | - | - | - | - | - |
Net Income |
-52.3 M | -54.2 M | 123 M | -81 M | -60.5 M | -52 M | -64.8 M | -22.4 M | -13.2 M | - | - | - | - |
Revenue |
392 K | 1.5 M | 208 M | 12.6 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 12.6 K | - | - | - | - | - | - | - | - | - |
Operating Income |
-59.3 M | -55.5 M | 124 M | -81.4 M | -61.4 M | -52.9 M | -65 M | -22.5 M | -13.2 M | - | - | - | - |
Interest Expense |
6.94 M | 1.38 M | -45.7 K | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-58.7 M | -55 M | 124 M | -81.1 M | -61.2 M | -52.8 M | -64.9 M | -22.5 M | -13.2 M | - | - | - | - |
Operating Expenses |
59.7 M | 57.1 M | 84.2 M | 94 M | 61.4 M | 52.9 M | 65 M | - | - | - | - | - | - |
General and Administrative Expenses |
31.1 M | 32.4 M | 37.2 M | 30.6 M | 19.3 M | 19.1 M | 15 M | 13 M | 6.58 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Ovid Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
70.7 M | 70.7 M | 70.6 M | 70.5 M | 70.5 M | 70.5 M | 70.4 M | 70.4 M | 70.3 M | 70.4 M | 67.9 M | 67.8 M | 66.1 M | 65.7 M | 59.4 M | 55.6 M | 54.7 M | 54.7 M | 54.7 M | 54.7 M | 54.7 M | 24.7 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 18.1 M | 9.84 M | 9.84 M | 9.84 M | 9.84 M | 9.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-11.7 M | - | -11.3 M | -12.4 M | -13.4 M | - | -12 M | -14.6 M | -16.1 M | - | -11.4 M | -15.8 M | 176 M | - | -16.4 M | -22.6 M | -20 M | -17 M | -16.6 M | -13.1 M | -13.8 M | -12.9 M | -13 M | -12.9 M | -13.2 M | -11 M | -9.36 M | -10.2 M | -34.2 M | -7.56 M | -5.78 M | -5.39 M | -3.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
148 K | - | 109 K | 75 K | 66 K | - | 11.1 K | - | 1.45 M | - | - | - | 208 M | - | 6.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-17.4 M | - | -12 M | -14.2 M | -14.9 M | - | -12.8 M | -14.3 M | -16.3 M | - | -11.7 M | -14.3 M | 177 M | - | -16.4 M | -23.1 M | -20.3 M | - | -16.8 M | -13.3 M | -14.1 M | - | -13.2 M | -13.2 M | -13.4 M | - | -9.41 M | -10.3 M | -34.3 M | - | -5.81 M | -5.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
5.72 M | - | 776 K | 1.76 M | 1.54 M | - | 836 K | -284 K | 209 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-17.3 M | - | -11.9 M | -14.1 M | -14.7 M | - | -12.7 M | -14.2 M | -16.2 M | - | -11.5 M | -14.2 M | 177 M | - | -16.2 M | -23 M | -20.2 M | - | -16.6 M | -13.2 M | -14 M | - | -13.1 M | -13.2 M | -13.4 M | - | -9.35 M | -10.3 M | -34.2 M | - | -5.79 M | -5.4 M | 5.9 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
17.6 M | - | 12.1 M | 14.2 M | 15 M | - | 12.8 M | 14.3 M | 17.7 M | - | 11.7 M | 14.3 M | 31.8 M | - | 23.3 M | 23.1 M | 20.3 M | 17.3 M | 16.8 M | 13.3 M | 14.1 M | 13.1 M | 13.2 M | 13.2 M | 13.4 M | 11 M | 9.41 M | 10.3 M | 34.3 M | 7.59 M | 5.82 M | 5.42 M | 3.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
7.17 M | - | 6.81 M | 8.25 M | 8.34 M | - | 7.63 M | 8.26 M | 9.88 M | - | 6.76 M | 6.63 M | 15.6 M | - | 7.44 M | 7.11 M | 5.67 M | - | 5.17 M | 4.2 M | 4.72 M | - | 4.63 M | 5.09 M | 4.96 M | - | 3.51 M | 4.21 M | 2.98 M | - | 3.12 M | 3.65 M | 2.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency